{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:25:30Z","timestamp":1786116330521,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,6]]},"DOI":"10.7759\/cureus.114044","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T09:15:57Z","timestamp":1786007757000},"source":"Crossref","is-referenced-by-count":0,"title":["Age-Related Time-to-Onset Analysis of Drug-Associated Erythema Multiforme Using the Japanese Adverse Drug Event Report Database"],"prefix":"10.7759","author":[{"given":"Hideyuki","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Sugishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomofumi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kageyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mugita","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Ino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57090921","article-title":"Recent updates in the treatment of erythema multiforme","volume":"57","author":"Soares A","year":"2021","unstructured":"Soares A, Sokumbi O. Recent updates in the treatment of erythema multiforme. Medicina (Kaunas). 2021, 57:921. 10.3390\/medicina57090921","journal-title":"Medicina (Kaunas)"},{"key":"ref2","article-title":"Erythema multiforme","volume":"74","author":"Lamoreux MR","year":"2006","unstructured":"Lamoreux MR, Sternbach MR, Hsu WT. Erythema multiforme. Am Fam Physician. 2006, 74:1883-8.","journal-title":"Am Fam Physician"},{"key":"ref3","article-title":"Erythema multiforme: recognition and management","volume":"100","author":"Trayes KP","year":"2019","unstructured":"Trayes KP, Love G, Studdiford JS. Erythema multiforme: recognition and management. Am Fam Physician. 2019, 100:82-8.","journal-title":"Am Fam Physician"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05348.x","article-title":"Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist","volume":"51","author":"Sokumbi O","year":"2012","unstructured":"Sokumbi O, Wetter DA. Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist. Int J Dermatol. 2012, 51:889-902. 10.1111\/j.1365-4632.2011.05348.x","journal-title":"Int J Dermatol"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.5070\/D37V35W30D","article-title":"Herpes simplex virus (HSV)-associated erythema multiforme (HAEM): a viral disease with an autoimmune component","volume":"9","author":"Aurelian L","year":"2003","unstructured":"Aurelian L, Ono F, Burnett J. Herpes simplex virus (HSV)-associated erythema multiforme (HAEM): a viral disease with an autoimmune component. Dermatol Online J. 2003, 9:1.","journal-title":"Dermatol Online J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2569","article-title":"Paediatric erythema multiforme: epidemiological, clinical and laboratory characteristics","volume":"97","author":"Siedner-Weintraub Y","year":"2017","unstructured":"Siedner-Weintraub Y, Gross I, David A, Reif S, Molho-Pessach V. Paediatric erythema multiforme: epidemiological, clinical and laboratory characteristics. Acta Derm Venereol. 2017, 97:489-92. 10.2340\/00015555-2569","journal-title":"Acta Derm Venereol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(01)01443-5","article-title":"Immunosenescence and infectious diseases","volume":"3","author":"Ginaldi L","year":"2001","unstructured":"Ginaldi L, Loreto MF, Corsi MP, Modesti M, De Martinis M. Immunosenescence and infectious diseases. Microbes Infect. 2001, 3:851-7. 10.1016\/S1286-4579(01)01443-5","journal-title":"Microbes Infect"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-017-0006-x","article-title":"The twilight of immunity: emerging concepts in aging of the immune system","volume":"19","author":"Nikolich-\u017dugich J","year":"2018","unstructured":"Nikolich-\u017dugich J. The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol. 2018, 19:10-9. 10.1038\/s41590-017-0006-x","journal-title":"Nat Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-022-00343-4","article-title":"Impaired CD4(+) T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination","volume":"3","author":"Jo N","year":"2023","unstructured":"Jo N, Hidaka Y, Kikuchi O, et al.. Impaired CD4(+) T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination. Nat Aging. 2023, 3:82-92. 10.1038\/s43587-022-00343-4","journal-title":"Nat Aging"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02279","article-title":"Sex hormones in acquired immunity and autoimmune disease","volume":"9","author":"Moulton VR","year":"2018","unstructured":"Moulton VR. Sex hormones in acquired immunity and autoimmune disease. Front Immunol. 2018, 9:2279. 10.3389\/fimmu.2018.02279","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/bies.201200099","article-title":"Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases","volume":"34","author":"Klein SL","year":"2012","unstructured":"Klein SL. Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases. Bioessays. 2012, 34:1050-9. 10.1002\/bies.201200099","journal-title":"Bioessays"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083849","article-title":"Multi-indication carbamazepine and the risk of severe cutaneous adverse drug reactions in Korean elderly patients: a Korean health insurance data-based study","volume":"8","author":"Kim JY","year":"2013","unstructured":"Kim JY, Lee J, Ko YJ, Shin JY, Jung SY, Choi NK, Park BJ. Multi-indication carbamazepine and the risk of severe cutaneous adverse drug reactions in Korean elderly patients: a Korean health insurance data-based study. PLoS One. 2013, 8:e83849. 10.1371\/journal.pone.0083849","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2023.03.004","article-title":"Reality of drug-induced erythema multiforme: a French pharmacovigilance study","volume":"78","author":"Demouche S","year":"2023","unstructured":"Demouche S, Bettuzzi T, Sbidian E, Laugier Castellan D, Osmont MN, Ingen-Housz-Oro S, Lebrun-Vignes B. Reality of drug-induced erythema multiforme: a French pharmacovigilance study. Therapie. 2023, 78:711-9. 10.1016\/j.therap.2023.03.004","journal-title":"Therapie"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2024.100936","article-title":"The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) - providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptions","volume":"17","author":"James F","year":"2024","unstructured":"James F, Goh MS, Vogrin S, et al.. The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) - providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptions. World Allergy Organ J. 2024, 17:100936. 10.1016\/j.waojou.2024.100936","journal-title":"World Allergy Organ J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132916","article-title":"Patterns of adverse drug reactions in different age groups: analysis of spontaneous reports by community pharmacists","volume":"10","author":"Yu YM","year":"2015","unstructured":"Yu YM, Shin WG, Lee JY, et al.. Patterns of adverse drug reactions in different age groups: analysis of spontaneous reports by community pharmacists. PLoS One. 2015, 10:e0132916. 10.1371\/journal.pone.0132916","journal-title":"PLoS One"},{"key":"ref16","unstructured":"Pharmaceuticals and Medical Devices Agency (PMDA). Suspected adverse drug reaction information. (2026). Accessed. July 11, 2026: https:\/\/www.pmda.go.jp\/safety\/info-services\/drugs\/adr-info\/suspected-adr\/0003.html."},{"key":"ref17","unstructured":"World Health Organization. ATC\/DDD toolkit. Anatomical therapeutic chemical (ATC) classification. (2026). Accessed: July 11, 2026: https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/atc-classification."},{"key":"ref18","unstructured":"International Council for Harmonisation of technical requirements for pharmaceuticals for human use (ICH). Medical Dictionary for Regulatory Activities (MedDRA). (2026). Accessed. July 11, 2026: https:\/\/www.ich.org\/page\/meddra."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in Python","volume":"17","author":"Virtanen P","year":"2020","unstructured":"Virtanen P, Gommers R, Oliphant TE, et al.. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods. 2020, 17:261-72. 10.1038\/s41592-019-0686-2","journal-title":"Nat Methods"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.21105\/joss.01317","article-title":"lifelines: survival analysis in Python","volume":"4","author":"Davidson-Pilon C","year":"2019","unstructured":"Davidson-Pilon C. lifelines: survival analysis in Python. J Open Source Softw. 2019, 4:1317. 10.21105\/joss.01317","journal-title":"J Open Source Softw"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2004.10.007","article-title":"Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations","volume":"97","author":"Phiel KL","year":"2005","unstructured":"Phiel KL, Henderson RA, Adelman SJ, Elloso MM. Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol Lett. 2005, 97:107-13. 10.1016\/j.imlet.2004.10.007","journal-title":"Immunol Lett"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2010.06.003","article-title":"Estrogen receptor profiles in human peripheral blood lymphocytes","volume":"132","author":"Pierdominici M","year":"2010","unstructured":"Pierdominici M, Maselli A, Colasanti T, et al.. Estrogen receptor profiles in human peripheral blood lymphocytes. Immunol Lett. 2010, 132:79-85. 10.1016\/j.imlet.2010.06.003","journal-title":"Immunol Lett"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126413","article-title":"Bias in spontaneous reporting of adverse drug reactions in Japan","volume":"10","author":"Matsuda S","year":"2015","unstructured":"Matsuda S, Aoki K, Kawamata T, et al.. Bias in spontaneous reporting of adverse drug reactions in Japan. PLoS One. 2015, 10:e0126413. 10.1371\/journal.pone.0126413","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1248\/bpbreports.9.3_57","article-title":"Analysis of bevacizumab-related hypertension using the Japanese Adverse Drug Event Report database","volume":"9","author":"Sugishita K","year":"2026","unstructured":"Sugishita K, Maeno M, Tanaka H, et al.. Analysis of bevacizumab-related hypertension using the Japanese Adverse Drug Event Report database. BPB Reports. 2026, 9:57-63. 10.1248\/bpbreports.9.3_57","journal-title":"BPB Reports"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.91376","article-title":"Evaluation of intraocular anti-vascular endothelial growth factor (VEGF) Drug-associated adverse events using spontaneous reporting databases","volume":"17","author":"Sato M","year":"2025","unstructured":"Sato M, Kageyama K, Ito S, et al.. Evaluation of intraocular anti-vascular endothelial growth factor (VEGF) Drug-associated adverse events using spontaneous reporting databases. Cureus. 2025, 17:e91376. 10.7759\/cureus.91376","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/517532-age-related-time-to-onset-analysis-of-drug-associated-erythema-multiforme-using-the-japanese-adverse-drug-event-report-database","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T09:15:58Z","timestamp":1786007758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/517532-age-related-time-to-onset-analysis-of-drug-associated-erythema-multiforme-using-the-japanese-adverse-drug-event-report-database"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.114044","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,6]]}}}